,Set,NGenes,Direction,PValue,FDR
1,WP_CREATINE_PATHWAY,2,Down,8.13760701480718e-05,0.0668911296617151
2,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.00033105071942782,0.106164594165574
3,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.000387462022502095,0.106164594165574
4,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.000573286482271679,0.11781037210683
5,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.00127220248456818,0.170998831611055
6,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,37,Down,0.00173746265325709,0.170998831611055
7,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.00174711359517645,0.170998831611055
8,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.00183438359653188,0.170998831611055
9,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.00187224998114293,0.170998831611055
10,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,22,Up,0.00233014247146913,0.191537711154762
11,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Up,0.00318113502976377,0.237717544951438
12,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.00409432826825132,0.23899664437052
13,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.00415327911314085,0.23899664437052
14,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.00429724875915262,0.23899664437052
15,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.00436125263449855,0.23899664437052
16,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.00471631603898931,0.242300736503076
17,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.00605243101908422,0.281031089152671
18,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.00632033209107311,0.281031089152671
19,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.00649585242567001,0.281031089152671
20,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.00704337310406534,0.289482634577085
21,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.00982890199339735,0.384731306598696
22,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.0104002913969275,0.388592705830656
23,WP_NRF2ARE_REGULATION,20,Up,0.0114124464986339,0.395302998563417
24,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,28,Down,0.0115416933887129,0.395302998563417
25,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.0121652846753327,0.39999456012494
26,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.013272703006794,0.402815075791479
27,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.0137211947958168,0.402815075791479
28,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.0137211947958168,0.402815075791479
29,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.0147539854266583,0.404443820669468
30,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.0151134523742322,0.404443820669468
31,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.0154055342601867,0.404443820669468
32,WP_BENZENE_METABOLISM,3,Up,0.0157447716075705,0.404443820669468
33,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,78,Down,0.0164953870860519,0.410885096507111
34,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.017605033200575,0.420858082109805
35,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.017919748021707,0.420858082109805
36,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.0184544495160224,0.421376597282512
37,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.0192655922144296,0.422782873347868
38,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.0195447070404124,0.422782873347868
39,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.0218785196217613,0.461131875104814
40,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.0230846093789487,0.474388722737395
41,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.0245540181436959,0.475740032863086
42,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.0260465565700297,0.475740032863086
43,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.0268032859542426,0.475740032863086
44,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.0269933254427433,0.475740032863086
45,WP_BURN_WOUND_HEALING,60,Down,0.0280397086815027,0.475740032863086
46,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.0284758155271412,0.475740032863086
47,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.0294155307497698,0.475740032863086
48,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.0305011393798876,0.475740032863086
49,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.0307812637255569,0.475740032863086
50,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.0307812637255569,0.475740032863086
51,WP_SPINAL_CORD_INJURY,66,Down,0.0308944306200042,0.475740032863086
52,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,41,Up,0.0309329578673579,0.475740032863086
53,WP_ARYLAMINE_METABOLISM,1,Up,0.0311164265682186,0.475740032863086
54,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.0321086392441175,0.475740032863086
55,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.0326762365067475,0.475740032863086
56,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0339887586007424,0.475740032863086
57,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.0341810603984296,0.475740032863086
58,WP_NEUROINFLAMMATION,10,Down,0.0344398584491726,0.475740032863086
59,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.0347321892762063,0.475740032863086
60,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.0352460806801347,0.475740032863086
61,WP_ASPIRIN_AND_MIRNAS,8,Down,0.0353043090080879,0.475740032863086
62,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.0367391882578395,0.486311267121743
63,WP_VITAMIN_B12_METABOLISM,23,Down,0.0372720314217394,0.486311267121743
64,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Down,0.0381241598720443,0.489657178356569
65,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0415100743977539,0.52132412553101
66,WP_INSULIN_SIGNALING,132,Down,0.0436063917656794,0.52132412553101
67,WP_DOPAMINE_METABOLISM,7,Up,0.0445875828378142,0.52132412553101
68,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.044609420766131,0.52132412553101
69,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.0456090077637902,0.52132412553101
70,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.045807551372057,0.52132412553101
71,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.0461276350580074,0.52132412553101
72,WP_NAD_METABOLISM,12,Down,0.0462968357966073,0.52132412553101
73,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.0462976413184473,0.52132412553101
74,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0489194319521755,0.542095232540195
75,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0498642043981919,0.542095232540195
76,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.0501207270961738,0.542095232540195
77,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.0518555171286097,0.549696472779567
78,WP_RANKLRANK_SIGNALING,48,Down,0.052160979168864,0.549696472779567
79,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.0530352755082796,0.551835398326656
80,WP_METHYLATION_PATHWAYS,5,Up,0.0542112778828711,0.552792232796563
81,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,84,Down,0.0550727522216441,0.552792232796563
82,WP_COPPER_HOMEOSTASIS,39,Up,0.0554649664197462,0.552792232796563
83,WP_PROSTAGLANDIN_SIGNALING,22,Down,0.0558172205865142,0.552792232796563
84,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.0575519343849075,0.557196032300787
85,WP_MAPK_CASCADE,30,Down,0.0576175945809816,0.557196032300787
86,WP_RETT_SYNDROME,32,Down,0.0595454362163687,0.569143588021571
87,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Up,0.0603939904408119,0.570619082095947
88,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.061245634012612,0.571841640791186
89,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.0626590657314491,0.571841640791186
90,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.0636769201941852,0.571841640791186
91,WP_GLUCURONIDATION,7,Up,0.0638208541391801,0.571841640791186
92,WP_FOLATE_METABOLISM,36,Down,0.0640017408184782,0.571841640791186
93,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.0648802075410743,0.57345731826627
94,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.0656161261922011,0.573792082233929
95,WP_TAMOXIFEN_METABOLISM,2,Up,0.0674534294630603,0.583649673880374
96,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,8,Down,0.0704516369511468,0.603242141394194
97,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.0742394685378797,0.614953625061034
98,WP_MACROPHAGE_MARKERS,8,Down,0.0745326234045851,0.614953625061034
99,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.074598602728558,0.614953625061034
100,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.0748118765281063,0.614953625061034
101,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.0771941544106714,0.619000360091794
102,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.0773782137333566,0.619000360091794
103,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.0780560579804766,0.619000360091794
104,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.0783163472622222,0.619000360091794
105,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,22,Up,0.079135884580163,0.61952092499899
106,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.0813247003180823,0.63065003454211
107,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.0822284489503726,0.631698925581367
108,WP_PDGFRBETA_PATHWAY,28,Up,0.0843916347079132,0.638428310798242
109,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.0847627182183263,0.638428310798242
110,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Up,0.0854344454839496,0.638428310798242
111,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.0872751673559934,0.64045788261748
112,WP_MONOAMINE_TRANSPORT,12,Down,0.087723386136153,0.64045788261748
113,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.0882204264357108,0.64045788261748
114,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,30,Down,0.0908744655522122,0.64045788261748
115,WP_OSTEOPONTIN_SIGNALING,11,Down,0.0914202459591969,0.64045788261748
116,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.0922940987192772,0.64045788261748
117,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.0924087569244457,0.64045788261748
118,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.0942274046998612,0.64045788261748
119,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.0952641829782226,0.64045788261748
120,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.0959848337472683,0.64045788261748
121,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.0960781763831881,0.64045788261748
122,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.0963690770461088,0.64045788261748
123,WP_IL1_SIGNALING,54,Down,0.0965716660203203,0.64045788261748
124,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0966140844824423,0.64045788261748
125,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.100045550204313,0.652339248016854
126,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.10011815592598,0.652339248016854
127,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.100787207418662,0.652339248016854
128,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.1038588420118,0.66696850104453
129,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.106067066285064,0.675869213072267
130,WP_GPCRS_OTHER,13,Down,0.107690616981859,0.680936055069911
131,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Up,0.109143102901814,0.68184734649104
132,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.109619467776489,0.68184734649104
133,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.110323232461446,0.68184734649104
134,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.112973634134039,0.687871389845053
135,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.114298764093147,0.687871389845053
136,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.114864372519237,0.687871389845053
137,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.115646976427749,0.687871389845053
138,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.115953904737075,0.687871389845053
139,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.116318884657497,0.687871389845053
140,WP_MAPK_SIGNALING,163,Down,0.12192380210485,0.715866895215621
141,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.123697632606263,0.716735411253509
142,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,52,Up,0.124410423553214,0.716735411253509
143,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.125077817761272,0.716735411253509
144,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Down,0.12893348979058,0.716735411253509
145,WP_KLEEFSTRA_SYNDROME,25,Down,0.129223369862743,0.716735411253509
146,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.130656408418051,0.716735411253509
147,WP_COMPLEMENT_SYSTEM,51,Up,0.130892738792222,0.716735411253509
148,WP_ANGIOGENESIS,14,Down,0.131169263286795,0.716735411253509
149,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.132657196140156,0.716735411253509
150,WP_FERROPTOSIS,50,Up,0.132883213937699,0.716735411253509
151,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.134295216365168,0.716735411253509
152,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.134301424466736,0.716735411253509
153,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.134889465348712,0.716735411253509
154,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.135301623666666,0.716735411253509
155,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.136454772799938,0.716735411253509
156,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.137275310525288,0.716735411253509
157,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.137567166312164,0.716735411253509
158,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.138707428505028,0.716735411253509
159,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.138712884794906,0.716735411253509
160,WP_NRF2_PATHWAY,71,Up,0.139794274692198,0.716735411253509
161,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,107,Down,0.140480697779151,0.716735411253509
162,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.141254424115655,0.716735411253509
163,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.147062655758666,0.741628852967014
164,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.149502807309027,0.748648660754647
165,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Down,0.151671314821316,0.748648660754647
166,WP_IL7_SIGNALING,23,Up,0.152487734784915,0.748648660754647
167,WP_ERBB_SIGNALING,69,Down,0.152637808690472,0.748648660754647
168,WP_MEASLES_VIRUS_INFECTION,100,Up,0.153008485409709,0.748648660754647
169,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.155104434850667,0.752274550343707
170,WP_LUNG_PATHOLOGY_OF_COVID19,14,Down,0.155987200406329,0.752274550343707
171,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,28,Up,0.156495070691939,0.752274550343707
172,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.163065686490192,0.768102721789219
173,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.163640293490272,0.768102721789219
174,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.164097503509339,0.768102721789219
175,WP_IL9_SIGNALING,15,Up,0.164299349994123,0.768102721789219
176,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,23,Up,0.165799986769074,0.768102721789219
177,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.166082491604847,0.768102721789219
178,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.166328813234162,0.768102721789219
179,WP_GLUTATHIONE_METABOLISM,10,Up,0.167481899419131,0.769106823030872
180,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.16894468918666,0.771514080619081
181,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.17008698511876,0.772439236285198
182,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.173426408974723,0.779402468648514
183,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.173567297353001,0.779402468648514
184,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.174887222329537,0.779402468648514
185,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.175412964355201,0.779402468648514
186,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.180942699184696,0.799649993171075
187,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.185532313008003,0.809023509994797
188,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.185969434355091,0.809023509994797
189,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.186016354487855,0.809023509994797
190,WP_ACUTE_VIRAL_MYOCARDITIS,65,Up,0.18736463555915,0.810598581208534
191,WP_TP53_NETWORK,16,Down,0.188725259498243,0.812210279097152
192,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Down,0.193179007835615,0.824564743373642
193,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.193602184271427,0.824564743373642
194,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.196479265033713,0.828923600444541
195,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.197629148363689,0.828923600444541
196,WP_PURINE_METABOLISM,10,Down,0.197650882831058,0.828923600444541
197,WP_JOUBERT_SYNDROME,72,Up,0.200356553041885,0.83015780519623
198,WP_IL19_SIGNALING,20,Up,0.200370735036664,0.83015780519623
199,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.201339264311068,0.83015780519623
200,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.202273207214745,0.83015780519623
201,WP_RETINOL_METABOLISM,6,Up,0.20612941189751,0.83015780519623
202,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.206906365698174,0.83015780519623
203,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.208240294997467,0.83015780519623
204,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.208358070295769,0.83015780519623
205,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.2088858847525,0.83015780519623
206,WP_HUNGER_AND_SATIETY,2,Up,0.209454366738412,0.83015780519623
207,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.209879210671807,0.83015780519623
208,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.210064262142112,0.83015780519623
209,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.212547475520023,0.83595227214095
210,WP_OVARIAN_INFERTILITY,21,Down,0.213944571355646,0.837440179306384
211,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.218351386332777,0.841524082705547
212,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.219042061350928,0.841524082705547
213,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.219874649496818,0.841524082705547
214,WP_CANCER_PATHWAYS,308,Up,0.222057085333287,0.841524082705547
215,WP_EGFEGFR_SIGNALING,141,Down,0.22357876569791,0.841524082705547
216,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.224816745385599,0.841524082705547
217,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.225019899804609,0.841524082705547
218,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Down,0.225281642055954,0.841524082705547
219,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.225755703575916,0.841524082705547
220,WP_IL18_SIGNALING,191,Down,0.226009855763023,0.841524082705547
221,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.230259283092804,0.841524082705547
222,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.230469588185063,0.841524082705547
223,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Down,0.230637856316243,0.841524082705547
224,WP_AXON_GUIDANCE,37,Down,0.231004593896362,0.841524082705547
225,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.231328915705195,0.841524082705547
226,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.23290928568506,0.841524082705547
227,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.233035178252187,0.841524082705547
228,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,31,Down,0.234475425421092,0.841524082705547
229,WP_IRON_METABOLISM_DISORDERS,10,Up,0.23483460993692,0.841524082705547
230,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.235766660171973,0.841524082705547
231,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.237404892441794,0.841524082705547
232,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.241253000000423,0.841524082705547
233,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.241253000000423,0.841524082705547
234,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Down,0.243072830634165,0.841524082705547
235,WP_IL5_SIGNALING,37,Up,0.243192826024719,0.841524082705547
236,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.245582446822549,0.841524082705547
237,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.246101967064843,0.841524082705547
238,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.247087050821727,0.841524082705547
239,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.247505958979227,0.841524082705547
240,WP_OREXIN_RECEPTOR_PATHWAY,119,Down,0.247794382167502,0.841524082705547
241,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Up,0.248011804089569,0.841524082705547
242,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.248618603389114,0.841524082705547
243,WP_EFFECTS_OF_MFN2_MUTATION,18,Down,0.249549139512449,0.841524082705547
244,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.249795469805539,0.841524082705547
245,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.250910233615643,0.841829436865546
246,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.253120198940444,0.845791884264412
247,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.255010457941767,0.84865828513414
248,WP_LUNG_FIBROSIS,33,Down,0.260467237202663,0.857068814625904
249,WP_REGULATION_OF_ACTIN_CYTOSKELETON,93,Down,0.263715494406377,0.857068814625904
250,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.264782326307242,0.857068814625904
251,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.266399281207036,0.857068814625904
252,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.268118956962707,0.857068814625904
253,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.268396537937263,0.857068814625904
254,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.268845009819127,0.857068814625904
255,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,15,Down,0.270319844436588,0.857068814625904
256,WP_PYRIMIDINE_METABOLISM,71,Down,0.270503758840996,0.857068814625904
257,WP_ESTROGEN_SIGNALING,21,Down,0.271579326875465,0.857068814625904
258,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.273351049810043,0.857068814625904
259,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.274100108312147,0.857068814625904
260,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Down,0.277555646046574,0.857068814625904
261,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.278259460467985,0.857068814625904
262,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Up,0.278797393211799,0.857068814625904
263,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.27887539800806,0.857068814625904
264,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.279202239352542,0.857068814625904
265,WP_HEME_BIOSYNTHESIS,8,Down,0.279202239352542,0.857068814625904
266,WP_SLEEP_REGULATION,11,Up,0.279316216324533,0.857068814625904
267,WP_GLIOBLASTOMA_SIGNALING,69,Down,0.280445227472948,0.857068814625904
268,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.281853862496836,0.857068814625904
269,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.28202970560514,0.857068814625904
270,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Up,0.282331180565285,0.857068814625904
271,WP_ZINC_HOMEOSTASIS,21,Up,0.283884990418384,0.857068814625904
272,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.285391041319156,0.857068814625904
273,WP_PEPTIDE_GPCRS,15,Up,0.285767864510436,0.857068814625904
274,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Down,0.286345388574721,0.857068814625904
275,WP_SMALL_CELL_LUNG_CANCER,70,Down,0.286732267666817,0.857068814625904
276,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.289165689701785,0.859960616384517
277,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.290477182986564,0.859960616384517
278,WP_PLEURAL_MESOTHELIOMA,255,Down,0.290838261988924,0.859960616384517
279,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.29277712358454,0.86259066518456
280,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,29,Down,0.29521484286347,0.864139428118691
281,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.296271202734521,0.864139428118691
282,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Down,0.29645659212831,0.864139428118691
283,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.298691555941954,0.86757759358405
284,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.303719737431302,0.878580853405096
285,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,176,Down,0.305413791204665,0.878580853405096
286,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.305686282328294,0.878580853405096
287,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.306922014601866,0.879058871089665
288,WP_SPINA_BIFIDA,10,Down,0.308163957160064,0.879551294394348
289,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Down,0.310938032484654,0.881214439665809
290,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.311047321240893,0.881214439665809
291,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.312645588368676,0.881214439665809
292,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.313034813117295,0.881214439665809
293,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.315595833412747,0.884852807742246
294,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Down,0.31648020130927,0.884852807742246
295,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.317906287365741,0.885094007491906
296,WP_NEPHROTIC_SYNDROME,27,Up,0.319188499261666,0.885094007491906
297,WP_NETRINUNC5B_SIGNALING,35,Down,0.320750908281607,0.885094007491906
298,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.323013330844115,0.885094007491906
299,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.323381440650898,0.885094007491906
300,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.324941342449205,0.885094007491906
301,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.325070590620008,0.885094007491906
302,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.325180523433766,0.885094007491906
303,WP_IL6_SIGNALING,38,Up,0.328888882713875,0.885809781968996
304,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.334315678587095,0.885809781968996
305,WP_KININKALLIKREIN_PATHWAY,2,Up,0.336035731659541,0.885809781968996
306,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.336396968582987,0.885809781968996
307,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.340088263563481,0.885809781968996
308,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Up,0.343027707204937,0.885809781968996
309,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.343502035997433,0.885809781968996
310,WP_ECTODERM_DIFFERENTIATION,78,Up,0.344761571144964,0.885809781968996
311,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.345726573320872,0.885809781968996
312,WP_FOXA2_PATHWAY,9,Down,0.347779561258184,0.885809781968996
313,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.349585659128195,0.885809781968996
314,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.350459951520168,0.885809781968996
315,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.350633519140806,0.885809781968996
316,WP_MTHFR_DEFICIENCY,18,Up,0.351164225603543,0.885809781968996
317,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,15,Up,0.35122033479975,0.885809781968996
318,WP_G_PROTEIN_SIGNALING,62,Up,0.35194283435255,0.885809781968996
319,WP_FOXP3_IN_COVID19,9,Up,0.352433024813236,0.885809781968996
320,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.352456038468686,0.885809781968996
321,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.353671730388138,0.885809781968996
322,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.354230757292662,0.885809781968996
323,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.354230757292662,0.885809781968996
324,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.354307188825013,0.885809781968996
325,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.355043615456573,0.885809781968996
326,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.355724918555917,0.885809781968996
327,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.355948175382807,0.885809781968996
328,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Up,0.356285233185653,0.885809781968996
329,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Down,0.356848216236964,0.885809781968996
330,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.356944310592296,0.885809781968996
331,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.358968609051554,0.885809781968996
332,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.359302168012707,0.885809781968996
333,WP_NUCLEAR_RECEPTORS,20,Down,0.361001163215931,0.885809781968996
334,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.361498492729984,0.885809781968996
335,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.361630465934802,0.885809781968996
336,WP_SERINE_METABOLISM,5,Down,0.362082830585867,0.885809781968996
337,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.364625764893036,0.889383913181233
338,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.369129820568718,0.895343976318443
339,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.369247698262716,0.895343976318443
340,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.372680878262394,0.901010829210846
341,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.375327219597842,0.904747725834093
342,WP_MESODERMAL_COMMITMENT_PATHWAY,77,Down,0.377976567983863,0.905170293691812
343,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.378504303606709,0.905170293691812
344,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.378806059647182,0.905170293691812
345,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.38565019793333,0.912817604109242
346,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.385675916019144,0.912817604109242
347,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.386544160274354,0.912817604109242
348,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.387526448871302,0.912817604109242
349,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.387558812450274,0.912817604109242
350,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.389497560672635,0.913074927600767
351,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.392003202435517,0.913074927600767
352,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.394178078328652,0.913074927600767
353,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.395659333740501,0.913074927600767
354,WP_IL11_SIGNALING,40,Up,0.397389170444382,0.913074927600767
355,WP_TNFALPHA_SIGNALING,84,Down,0.397517447649254,0.913074927600767
356,WP_PDGF_PATHWAY,37,Down,0.397849116054305,0.913074927600767
357,WP_DRAVET_SYNDROME,15,Down,0.398023038494588,0.913074927600767
358,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.398709670358552,0.913074927600767
359,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.3990610972386,0.913074927600767
360,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.399988479090005,0.913074927600767
361,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.401608206521823,0.913074927600767
362,WP_PPARALPHA_PATHWAY,15,Down,0.402108423103987,0.913074927600767
363,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,18,Down,0.403853227437631,0.914510614197611
364,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.409104259025243,0.9146274231009
365,WP_NEURAL_CREST_DIFFERENTIATION,41,Down,0.409848543333867,0.9146274231009
366,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.410654832958342,0.9146274231009
367,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.415385752134585,0.9146274231009
368,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.415721076888746,0.9146274231009
369,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.416014407643353,0.9146274231009
370,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.416837980795593,0.9146274231009
371,WP_TRANSLATION_FACTORS,49,Down,0.417076097624279,0.9146274231009
372,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.41783734312517,0.9146274231009
373,WP_ID_SIGNALING,12,Down,0.419550591186259,0.9146274231009
374,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.420337215076977,0.9146274231009
375,WP_SELENIUM_MICRONUTRIENT_NETWORK,49,Down,0.42166901967076,0.9146274231009
376,WP_SEROTONIN_AND_ANXIETY,8,Down,0.42172272842717,0.9146274231009
377,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.422771907218547,0.9146274231009
378,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.423079556258564,0.9146274231009
379,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.423319760348245,0.9146274231009
380,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.426472577326159,0.9146274231009
381,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.426718441651955,0.9146274231009
382,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.42831857815549,0.9146274231009
383,WP_G13_SIGNALING,29,Down,0.428582205238496,0.9146274231009
384,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Down,0.429316726995792,0.9146274231009
385,WP_SYNAPTIC_VESICLE_PATHWAY,23,Down,0.430237616658369,0.9146274231009
386,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.430277391695532,0.9146274231009
387,WP_PI3KAKT_SIGNALING,178,Up,0.430914074317589,0.9146274231009
388,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.43219537334581,0.9146274231009
389,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.432834632100061,0.9146274231009
390,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Down,0.434592000632608,0.915986216717957
391,WP_DNA_MISMATCH_REPAIR,21,Down,0.436157460395761,0.916934609834567
392,WP_IRINOTECAN_PATHWAY,5,Up,0.438939689852588,0.917458445482569
393,WP_CYTOSINE_METHYLATION,7,Up,0.439315020187104,0.917458445482569
394,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.441433585740194,0.917458445482569
395,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.443373308941306,0.917458445482569
396,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.443669220593134,0.917458445482569
397,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.445504380706725,0.917458445482569
398,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.446475167485632,0.917458445482569
399,WP_SMALL_LIGAND_GPCRS,7,Up,0.448071576255367,0.917458445482569
400,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.448681884301166,0.917458445482569
401,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.448772813542987,0.917458445482569
402,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.449211580148232,0.917458445482569
403,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.449800186775517,0.917458445482569
404,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.455347270330505,0.923682777900045
405,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.456512439145199,0.923682777900045
406,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.460592173454996,0.923682777900045
407,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.460721994153522,0.923682777900045
408,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.46085273379406,0.923682777900045
409,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.463983871126278,0.923682777900045
410,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.464306656547158,0.923682777900045
411,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.464790381214463,0.923682777900045
412,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.465470517673949,0.923682777900045
413,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.469526167255738,0.923682777900045
414,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.469583521943415,0.923682777900045
415,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.472579177954191,0.923682777900045
416,WP_TAR_SYNDROME,43,Down,0.473022656511292,0.923682777900045
417,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.476159810318282,0.923682777900045
418,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.476474921145481,0.923682777900045
419,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.476479354248571,0.923682777900045
420,WP_BDNFTRKB_SIGNALING,27,Down,0.476577435500059,0.923682777900045
421,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.476610349570726,0.923682777900045
422,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,80,Down,0.477184848988951,0.923682777900045
423,WP_IL2_SIGNALING,37,Up,0.477414182687707,0.923682777900045
424,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.480656554748378,0.923682777900045
425,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,166,Up,0.481181374382667,0.923682777900045
426,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.482841651934792,0.923682777900045
427,WP_THERMOGENESIS,74,Down,0.4832876684667,0.923682777900045
428,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Down,0.483614927515278,0.923682777900045
429,WP_MALE_INFERTILITY,68,Down,0.485275554984234,0.923682777900045
430,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,93,Down,0.485882757096848,0.923682777900045
431,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.486455945775353,0.923682777900045
432,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.488044579950524,0.923682777900045
433,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.488103267254288,0.923682777900045
434,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.488464811176019,0.923682777900045
435,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,26,Down,0.488972306653658,0.923682777900045
436,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.490231150714626,0.923682777900045
437,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,48,Down,0.49377660514597,0.923682777900045
438,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.493856083209346,0.923682777900045
439,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.494015920802068,0.923682777900045
440,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.496115660225847,0.923682777900045
441,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.497211356584102,0.923682777900045
442,WP_PPAR_SIGNALING,39,Down,0.497533952611658,0.923682777900045
443,WP_GPR40_PATHWAY,9,Up,0.499051179428265,0.923682777900045
444,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Up,0.500042263720331,0.923682777900045
445,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.500683244252634,0.923682777900045
446,WP_HIPPO_SIGNALING_REGULATION,44,Down,0.501170947619733,0.923682777900045
447,WP_APOPTOSIS,72,Down,0.507900471082917,0.932344807882945
448,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Down,0.509051277867769,0.932344807882945
449,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.510187185389236,0.932344807882945
450,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.510407741541758,0.932344807882945
451,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Up,0.512225939195199,0.933591401371295
452,WP_IL26_SIGNALING,31,Down,0.513980004649927,0.934715849164248
453,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Up,0.516875382520285,0.936820310301271
454,WP_PROLACTIN_SIGNALING,69,Down,0.519845535619224,0.936820310301271
455,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.520360104578973,0.936820310301271
456,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.521687768223175,0.936820310301271
457,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.522139916844824,0.936820310301271
458,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Up,0.522977316208673,0.936820310301271
459,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.524719187471652,0.936820310301271
460,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.524835981422907,0.936820310301271
461,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.526293186837155,0.936820310301271
462,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.52669532060663,0.936820310301271
463,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.529420124044496,0.936820310301271
464,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,15,Up,0.530705191454878,0.936820310301271
465,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.532923318686626,0.936820310301271
466,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.534250128856124,0.936820310301271
467,WP_CHEMOKINE_SIGNALING,110,Down,0.5344449226856,0.936820310301271
468,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.535263749286333,0.936820310301271
469,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.535550108505901,0.936820310301271
470,WP_CAMKK2_PATHWAY,30,Up,0.535651515622381,0.936820310301271
471,WP_TCELL_RECEPTOR_SIGNALING,74,Down,0.541137542853421,0.941941472994721
472,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.541952348814241,0.941941472994721
473,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.542383889562315,0.941941472994721
474,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.543756132450614,0.941941472994721
475,WP_MELANOMA,55,Down,0.54541005602379,0.941941472994721
476,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.545455159544388,0.941941472994721
477,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.549299330338805,0.945839198960912
478,WP_MONOAMINE_GPCRS,3,Up,0.550692961704266,0.945839198960912
479,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.551164204747295,0.945839198960912
480,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Up,0.553106952917503,0.947195656871225
481,WP_MATRIX_METALLOPROTEINASES,8,Down,0.554327430848598,0.9473121583317
482,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.560465052006729,0.948660996351712
483,WP_HIPPOYAP_SIGNALING,16,Up,0.560727430849664,0.948660996351712
484,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.563071483201659,0.948660996351712
485,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Up,0.563387149235883,0.948660996351712
486,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.5635531622515,0.948660996351712
487,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,49,Down,0.563928813115837,0.948660996351712
488,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.563935831596138,0.948660996351712
489,WP_OSTEOCLAST_SIGNALING,9,Up,0.564877326834766,0.948660996351712
490,WP_STEROID_BIOSYNTHESIS,3,Down,0.565934392031095,0.948660996351712
491,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Up,0.566657602443663,0.948660996351712
492,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.570040435573975,0.950002296590965
493,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.571742268812759,0.950002296590965
494,WP_MEVALONATE_PATHWAY,7,Up,0.57642385260476,0.950002296590965
495,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.576884188976035,0.950002296590965
496,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.577386512541802,0.950002296590965
497,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,91,Up,0.578569774052099,0.950002296590965
498,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.578706843676342,0.950002296590965
499,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.579053098722266,0.950002296590965
500,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.579419325988861,0.950002296590965
501,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.579885284083163,0.950002296590965
502,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,31,Down,0.580547415344248,0.950002296590965
503,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.581327439398121,0.950002296590965
504,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.582861342663515,0.950619094582161
505,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.584374623396571,0.951199882043527
506,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.5858309760469,0.95168589389437
507,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.589426507096744,0.955638242275194
508,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.595667189575966,0.958666179690735
509,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.596797303536009,0.958666179690735
510,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.597626640860603,0.958666179690735
511,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Down,0.598432968317156,0.958666179690735
512,WP_PURINERGIC_SIGNALING,15,Down,0.599505560489574,0.958666179690735
513,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.600696462697128,0.958666179690735
514,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.600931539665728,0.958666179690735
515,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.603184791043558,0.958666179690735
516,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Up,0.603275698225433,0.958666179690735
517,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.604338240226583,0.958666179690735
518,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.604429956919616,0.958666179690735
519,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.60945515552283,0.958666179690735
520,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.610525410755374,0.958666179690735
521,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.611326067920491,0.958666179690735
522,WP_ENDOTHELIN_PATHWAYS,12,Up,0.611499854021094,0.958666179690735
523,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.611691994706282,0.958666179690735
524,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.612243367342116,0.958666179690735
525,WP_SILDENAFIL_TREATMENT,11,Down,0.612286793598097,0.958666179690735
526,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.614792944117464,0.959294603309954
527,WP_CELLULAR_PROTEOSTASIS,6,Up,0.615022209178036,0.959294603309954
528,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,4,Up,0.620728686000754,0.96635886810201
529,WP_IL3_SIGNALING,46,Up,0.622972887361481,0.96635886810201
530,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Up,0.623078102304216,0.96635886810201
531,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.625948962895752,0.967596307820226
532,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.626230213820389,0.967596307820226
533,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.627905894165578,0.968365187624963
534,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.63643869288346,0.979686527247573
535,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.641879112712937,0.983458611589557
536,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.64386895326111,0.983458611589557
537,WP_NPHP1_DELETION_SYNDROME,10,Down,0.644732196746864,0.983458611589557
538,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Down,0.645054151266583,0.983458611589557
539,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.645435725002966,0.983458611589557
540,WP_ALLOGRAFT_REJECTION,50,Down,0.646270281616016,0.983458611589557
541,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Up,0.647264122712835,0.983458611589557
542,WP_BASE_EXCISION_REPAIR,29,Down,0.652465752023447,0.984123368378009
543,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Down,0.652565551023839,0.984123368378009
544,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.65349496552549,0.984123368378009
545,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.653578650504675,0.984123368378009
546,WP_HYPERTROPHY_MODEL,13,Down,0.653687784835028,0.984123368378009
547,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.6571418931889,0.985172788892002
548,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.659241705173487,0.985172788892002
549,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.661295876436777,0.985172788892002
550,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.661388483082857,0.985172788892002
551,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.661664743701772,0.985172788892002
552,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.663062816278934,0.985172788892002
553,WP_COMPLEMENT_ACTIVATION,12,Up,0.664956061020938,0.985172788892002
554,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.665779963926415,0.985172788892002
555,WP_ONECARBON_METABOLISM,22,Up,0.671137249962027,0.985172788892002
556,WP_BARDETBIEDL_SYNDROME,65,Up,0.671201723938247,0.985172788892002
557,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.672754011257965,0.985172788892002
558,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.67630200584149,0.985172788892002
559,WP_INTEGRATED_CANCER_PATHWAY,41,Up,0.676574209323832,0.985172788892002
560,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.677697895848871,0.985172788892002
561,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.679534910196533,0.985172788892002
562,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.682031170640648,0.985172788892002
563,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.683128619339425,0.985172788892002
564,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.683347574263929,0.985172788892002
565,WP_PREIMPLANTATION_EMBRYO,21,Down,0.683675777083215,0.985172788892002
566,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.684889988116265,0.985172788892002
567,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.685747862474392,0.985172788892002
568,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.687399235780194,0.985172788892002
569,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Up,0.689036157927698,0.985172788892002
570,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.69122406552623,0.985172788892002
571,WP_OSTEOBLAST_SIGNALING,3,Down,0.693715538304375,0.985172788892002
572,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Down,0.69394950437422,0.985172788892002
573,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.695469533805538,0.985172788892002
574,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.697153056131229,0.985172788892002
575,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.697507735586064,0.985172788892002
576,WP_CORI_CYCLE,11,Down,0.69927294469385,0.985172788892002
577,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Down,0.699308196418098,0.985172788892002
578,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.699488906015705,0.985172788892002
579,WP_KALLMANN_SYNDROME,11,Up,0.701068422405553,0.985172788892002
580,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.701425272821092,0.985172788892002
581,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.705901270643003,0.985172788892002
582,WP_GPCRS_CLASS_A_RHODOPSINLIKE,43,Down,0.709215068543403,0.985172788892002
583,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.709434166461413,0.985172788892002
584,WP_AUTOPHAGY,27,Down,0.709744773711937,0.985172788892002
585,WP_GASTRIN_SIGNALING,93,Down,0.711529321146093,0.985172788892002
586,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.713186279189871,0.985172788892002
587,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,72,Up,0.71332101465504,0.985172788892002
588,WP_ENDODERM_DIFFERENTIATION,84,Down,0.7138849712318,0.985172788892002
589,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,41,Down,0.714311438687219,0.985172788892002
590,WP_CELL_CYCLE,96,Up,0.714433904429564,0.985172788892002
591,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,5,Down,0.714553320977755,0.985172788892002
592,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.716703731545326,0.985172788892002
593,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.71676087760042,0.985172788892002
594,WP_NUCLEOTIDE_GPCRS,5,Up,0.717429232906524,0.985172788892002
595,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Down,0.717504500143028,0.985172788892002
596,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.719092317430849,0.985172788892002
597,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.719121463401276,0.985172788892002
598,WP_5Q35_COPY_NUMBER_VARIATION,77,Up,0.71999532875319,0.985172788892002
599,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Down,0.72083515695967,0.985172788892002
600,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Down,0.724202189534648,0.985172788892002
601,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Up,0.726125678424617,0.985172788892002
602,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,58,Up,0.729207437848437,0.985172788892002
603,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.729590346618241,0.985172788892002
604,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.731585441562059,0.985172788892002
605,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.732063336871024,0.985172788892002
606,WP_BLADDER_CANCER,29,Down,0.732263620450768,0.985172788892002
607,WP_VITAMIN_B12_DISORDERS,9,Up,0.733693535143811,0.985172788892002
608,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.733826720796339,0.985172788892002
609,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.734326040216124,0.985172788892002
610,WP_IL17_SIGNALING,25,Down,0.734586570388689,0.985172788892002
611,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Up,0.735053935991674,0.985172788892002
612,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.737093170463021,0.985172788892002
613,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.738733751493257,0.985172788892002
614,WP_HEART_DEVELOPMENT,17,Up,0.738971140993168,0.985172788892002
615,WP_7OXOC_AND_7BETAHC_PATHWAYS,18,Up,0.739832436101605,0.985172788892002
616,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.741185816479166,0.985172788892002
617,WP_SULFATASE_AND_AROMATASE_PATHWAY,4,Up,0.741306957925591,0.985172788892002
618,WP_ENDOMETRIAL_CANCER,49,Down,0.742746262203965,0.985172788892002
619,WP_VITAMIN_D_RECEPTOR_PATHWAY,84,Down,0.74381536649093,0.985172788892002
620,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.744791069411085,0.985172788892002
621,WP_RAC1PAK1P38MMP2_PATHWAY,51,Up,0.746528475423462,0.985172788892002
622,WP_RAS_SIGNALING,117,Up,0.746657179448125,0.985172788892002
623,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.747186210426197,0.985172788892002
624,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Down,0.748365755963877,0.985172788892002
625,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Up,0.750509520998592,0.985172788892002
626,WP_LEPTIN_SIGNALING,70,Down,0.751062547609746,0.985172788892002
627,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.751463915614702,0.985172788892002
628,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.753805362890136,0.985847067990584
629,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.75536882204248,0.985847067990584
630,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Down,0.755576219992783,0.985847067990584
631,WP_ADIPOGENESIS,86,Down,0.759394490120589,0.988740030405102
632,WP_CHOLESTEROL_METABOLISM,53,Up,0.76019914746475,0.988740030405102
633,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.762506734641691,0.989339927852192
634,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.763067535594027,0.989339927852192
635,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,126,Up,0.764428739188776,0.989543974193975
636,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.766092830110679,0.989870436499535
637,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,22,Up,0.768216130990057,0.989870436499535
638,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.768807637140398,0.989870436499535
639,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.769497821074456,0.989870436499535
640,WP_VITAMIN_D_METABOLISM,6,Down,0.770704759572058,0.989873925575361
641,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.772989478944466,0.989915661774865
642,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.774885875940587,0.989915661774865
643,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.776800238427727,0.989915661774865
644,WP_NRXN1_DELETION_SYNDROME,2,Down,0.779683590264258,0.989915661774865
645,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.780003354843891,0.989915661774865
646,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.781449093316811,0.989915661774865
647,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.784556504764297,0.989915661774865
648,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.785238539930701,0.989915661774865
649,WP_ENERGY_METABOLISM,41,Down,0.785963776263224,0.989915661774865
650,WP_NUCLEAR_RECEPTORS_METAPATHWAY,177,Up,0.786146118515927,0.989915661774865
651,WP_FOCAL_ADHESION,119,Down,0.788217023160604,0.989915661774865
652,WP_WNT_SIGNALING_WP363,39,Down,0.788973743151325,0.989915661774865
653,WP_ALSTROM_SYNDROME,27,Up,0.798250801057123,0.989915661774865
654,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,73,Down,0.798806754641565,0.989915661774865
655,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.801609019662627,0.989915661774865
656,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.802929013333228,0.989915661774865
657,WP_PHOSPHOINOSITIDES_METABOLISM,39,Down,0.803922669706565,0.989915661774865
658,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,22,Up,0.806213482225181,0.989915661774865
659,WP_BREAST_CANCER_PATHWAY,88,Down,0.809871842141846,0.989915661774865
660,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Down,0.809878958604832,0.989915661774865
661,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.809887398568018,0.989915661774865
662,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.811069851685477,0.989915661774865
663,WP_CILIOPATHIES,128,Up,0.811286723423801,0.989915661774865
664,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.813753478254262,0.989915661774865
665,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,16,Down,0.813776410995405,0.989915661774865
666,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.816610496142453,0.989915661774865
667,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Up,0.816817334634987,0.989915661774865
668,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.818199753664127,0.989915661774865
669,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Down,0.821841115000801,0.989915661774865
670,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.821922093525653,0.989915661774865
671,WP_HISTONE_MODIFICATIONS,37,Down,0.822152933378461,0.989915661774865
672,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.825328485935271,0.989915661774865
673,WP_ALZHEIMERS_DISEASE,184,Up,0.82681816050844,0.989915661774865
674,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Up,0.82681816050844,0.989915661774865
675,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,272,Down,0.828195794619298,0.989915661774865
676,WP_ATM_SIGNALING,34,Down,0.82892729345859,0.989915661774865
677,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.829035939355829,0.989915661774865
678,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.829728936573897,0.989915661774865
679,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.831301198943256,0.989915661774865
680,WP_TRYPTOPHAN_METABOLISM,19,Up,0.831685534227746,0.989915661774865
681,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.832308903448875,0.989915661774865
682,WP_CHOLESTASIS,9,Up,0.832583973225059,0.989915661774865
683,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.832741414492887,0.989915661774865
684,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.83355664955633,0.989915661774865
685,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.83409262730951,0.989915661774865
686,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,48,Down,0.835052308059245,0.989915661774865
687,WP_AGERAGE_PATHWAY,54,Down,0.835803806911576,0.989915661774865
688,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.835809985102088,0.989915661774865
689,WP_HEPATITIS_B_INFECTION,117,Up,0.835936206985677,0.989915661774865
690,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.837392912618829,0.989915661774865
691,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.838144377089501,0.989915661774865
692,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.838998705856878,0.989915661774865
693,WP_DNA_REPLICATION,36,Down,0.840433441530142,0.989915661774865
694,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.841026199418435,0.989915661774865
695,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.843472855455659,0.989915661774865
696,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.844995770284985,0.989915661774865
697,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.845974618611837,0.989915661774865
698,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Up,0.847273678363448,0.989915661774865
699,WP_NONSMALL_CELL_LUNG_CANCER,61,Down,0.850005218029194,0.989915661774865
700,WP_SPHINGOLIPID_PATHWAY,20,Down,0.851533018791787,0.989915661774865
701,WP_RETINOBLASTOMA_GENE_IN_CANCER,73,Down,0.851997669079965,0.989915661774865
702,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.85254940082608,0.989915661774865
703,WP_PRIMARY_OVARIAN_INSUFFICIENCY,88,Up,0.853283340607094,0.989915661774865
704,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Up,0.853623195406458,0.989915661774865
705,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Down,0.854527094404249,0.989915661774865
706,WP_CIRCADIAN_RHYTHM_GENES,121,Up,0.855849726528908,0.989915661774865
707,WP_CCL18_SIGNALING,20,Up,0.856025950165935,0.989915661774865
708,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Up,0.857766056387065,0.989915661774865
709,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.858037219916012,0.989915661774865
710,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.858049250804341,0.989915661774865
711,WP_IDO_METABOLIC_PATHWAY,8,Down,0.858435690538527,0.989915661774865
712,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.858677096242039,0.989915661774865
713,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Up,0.859378798528531,0.989915661774865
714,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.865791185613473,0.989915661774865
715,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.867257932629937,0.989915661774865
716,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,87,Down,0.868018502363588,0.989915661774865
717,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.870412361427265,0.989915661774865
718,WP_G1_TO_S_CELL_CYCLE_CONTROL,52,Down,0.870574498217012,0.989915661774865
719,WP_MRNA_PROCESSING,124,Up,0.870891937898111,0.989915661774865
720,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.873279508233832,0.989915661774865
721,WP_VALPROIC_ACID_PATHWAY,9,Down,0.873520402495468,0.989915661774865
722,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,0.873561056808795,0.989915661774865
723,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,18,Up,0.873757330369201,0.989915661774865
724,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.87396772106401,0.989915661774865
725,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.874279611563897,0.989915661774865
726,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.875343158870677,0.989915661774865
727,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.876440109056444,0.989915661774865
728,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.876713627459978,0.989915661774865
729,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.879368353358865,0.990893445226816
730,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.881144782575455,0.990893445226816
731,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.881936037524838,0.990893445226816
732,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Down,0.88259571462897,0.990893445226816
733,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.883606928651163,0.990893445226816
734,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.885470690403176,0.991630664184483
735,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Up,0.887328751885189,0.992268046537401
736,WP_NEPHROGENESIS,4,Up,0.889164051351489,0.992268046537401
737,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.891733245299729,0.992268046537401
738,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.893763897450776,0.992268046537401
739,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.894000640327548,0.992268046537401
740,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Down,0.894021165755773,0.992268046537401
741,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.894751955772368,0.992268046537401
742,WP_EICOSANOID_SYNTHESIS,13,Up,0.895923476655837,0.992268046537401
743,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.900763757736123,0.992268046537401
744,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Up,0.900784874470521,0.992268046537401
745,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Down,0.901425102131946,0.992268046537401
746,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.90239258310593,0.992268046537401
747,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Down,0.902766792218009,0.992268046537401
748,WP_ATR_SIGNALING,10,Up,0.903424055786017,0.992268046537401
749,WP_MIRNA_BIOGENESIS,6,Up,0.905068610129261,0.992268046537401
750,WP_TGFB_SMAD_SIGNALING,7,Down,0.906465597654158,0.992268046537401
751,WP_KREBS_CYCLE_DISORDERS,11,Up,0.908265083445441,0.992268046537401
752,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.909221391293549,0.992268046537401
753,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.909800964362454,0.992268046537401
754,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.910182612030657,0.992268046537401
755,WP_PROTEASOME_DEGRADATION,57,Down,0.913028120351034,0.992692183020278
756,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.913650217201512,0.992692183020278
757,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.914576504372945,0.992692183020278
758,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.918303552827621,0.992692183020278
759,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.918467469719348,0.992692183020278
760,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.920983599564463,0.992692183020278
761,WP_VEGFAVEGFR2_SIGNALING,342,Up,0.922883871241166,0.992692183020278
762,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.923487611323183,0.992692183020278
763,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.924104562161565,0.992692183020278
764,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,65,Up,0.925407301645551,0.992692183020278
765,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.92611622731298,0.992692183020278
766,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.92684198539505,0.992692183020278
767,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.927039849378215,0.992692183020278
768,WP_P38_MAPK_SIGNALING,31,Down,0.928530167450876,0.992692183020278
769,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Up,0.930304743419683,0.992692183020278
770,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.931937572236934,0.992692183020278
771,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.932224140834158,0.992692183020278
772,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.933185638520058,0.992692183020278
773,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Down,0.933970118517699,0.992692183020278
774,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.934724756274568,0.992692183020278
775,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.938970118367861,0.995914112643073
776,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.940620671460772,0.996379113325715
777,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.942842513543716,0.996519176489686
778,WP_DNA_DAMAGE_RESPONSE,59,Up,0.944105838072906,0.996519176489686
779,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Up,0.945969584228779,0.996519176489686
780,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.946201582755758,0.996519176489686
781,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.947468665868862,0.996519176489686
782,WP_PRION_DISEASE_PATHWAY,28,Down,0.948026759142256,0.996519176489686
783,WP_AMINO_ACID_METABOLISM,59,Up,0.949645831784163,0.996838222265936
784,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.95389062097487,0.996838222265936
785,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.956395343627362,0.996838222265936
786,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.956586261421151,0.996838222265936
787,WP_NOTCH_SIGNALING_WP61,49,Down,0.957326182294713,0.996838222265936
788,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.95795537217891,0.996838222265936
789,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.960737713772405,0.996838222265936
790,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.961045599616201,0.996838222265936
791,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.964990747462996,0.996838222265936
792,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.966496133310166,0.996838222265936
793,WP_CILIARY_LANDSCAPE,185,Down,0.968005635524868,0.996838222265936
794,WP_FRAGILE_X_SYNDROME,84,Up,0.968914798967213,0.996838222265936
795,WP_WNT_SIGNALING_WP428,60,Down,0.971426956002877,0.996838222265936
796,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.971789941470732,0.996838222265936
797,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,61,Down,0.972258255274771,0.996838222265936
798,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Up,0.972475612736592,0.996838222265936
799,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,136,Down,0.974521962227859,0.996838222265936
800,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.976289526733666,0.996838222265936
801,WP_AEROBIC_GLYCOLYSIS,10,Up,0.978507064155092,0.996838222265936
802,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.978507064155092,0.996838222265936
803,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.979179463099095,0.996838222265936
804,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.97949558824276,0.996838222265936
805,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.980182221139957,0.996838222265936
806,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.980328753907724,0.996838222265936
807,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Up,0.982600560272575,0.996838222265936
808,WP_GLYOXYLATE_METABOLISM,5,Up,0.98266668056761,0.996838222265936
809,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.983968347795369,0.996838222265936
810,WP_NOTCH_SIGNALING_WP268,35,Up,0.984131810457567,0.996838222265936
811,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Up,0.984264576094968,0.996838222265936
812,WP_IL4_SIGNALING,50,Up,0.984973011095241,0.996838222265936
813,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.985923935160834,0.996838222265936
814,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,70,Down,0.988685101336614,0.997255926989507
815,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,74,Up,0.989724919274196,0.997255926989507
816,WP_TRANSSULFURATION_PATHWAY,8,Up,0.990233055691655,0.997255926989507
817,WP_4P163_COPY_NUMBER_VARIATION,22,Down,0.991189893370349,0.997255926989507
818,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,44,Up,0.993263667486109,0.998120702534941
819,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.995779000452415,0.998814892120014
820,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.998116794549959,0.998814892120014
821,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.998814892120014,0.998814892120014
822,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.998814892120014,0.998814892120014
